» Articles » PMID: 39590211

Beyond the Obesity Paradox: Analysis of New Prognostic Factors in Transcatheter Aortic Valve Implantation Procedure

Abstract

Scope: The main purpose of our study was to collect computed tomography (CT) measurements of fat parameters that are significantly related to body mass index (BMI) and evaluate the associations of these measurements and sarcopenia with early and long-term complications after transcatheter aortic valve implantation (TAVI) in order to investigate the existence of the so-called 'obesity paradox' and the role of sarcopenia in this phenomenon.

Materials And Methods: We analyzed the significance of fat CT measurements in 85 patients undergoing the TAVI procedure and compared these with each other, as well as with quantified CT BMI and fat density measurements. Secondly, we evaluated the associations of BMI, CT measurements of fat, and CT evaluations of skeletal muscle mass with early and long-term complications after 24 months of post-TAVI follow-up.

Results: We found positive and significant relationships between fat CT measurements with each other and with BMI and a negative and significant relation between fat density and fat quantity. By comparing the CT measurements of fat and skeletal muscle mass with early and long-term complications after TAVI, we confirmed the existence of the 'obesity paradox' and the poor effect of sarcopenia after the TAVI procedure.

Conclusions: We confirm that overweight and obesity are good prognostic factors, and sarcopenia is a poor prognostic factor for outcomes following the TAVI procedure. We focused on the scientific validation of an easy and fast way to measure fat and skeletal muscle mass using CT to better predict the outcomes of patients undergoing TAVI.

References
1.
Yamamoto M, Mouillet G, Oguri A, Gilard M, Laskar M, Eltchaninoff H . Effect of body mass index on 30- and 365-day complication and survival rates of transcatheter aortic valve implantation (from the FRench Aortic National CoreValve and Edwards 2 [FRANCE 2] registry). Am J Cardiol. 2013; 112(12):1932-7. DOI: 10.1016/j.amjcard.2013.08.022. View

2.
Chiocchi M, Ricci F, Pasqualetto M, DErrico F, Benelli L, Pugliese L . Role of computed tomography in transcatheter aortic valve implantation and valve-in-valve implantation: complete review of preprocedural and postprocedural imaging. J Cardiovasc Med (Hagerstown). 2020; 21(3):182-191. DOI: 10.2459/JCM.0000000000000899. View

3.
Blanke P, Weir-McCall J, Achenbach S, Delgado V, Hausleiter J, Jilaihawi H . Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI) / transcatheter aortic valve replacement (TAVR): An expert consensus document of the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr. 2019; 13(1):1-20. DOI: 10.1016/j.jcct.2018.11.008. View

4.
Mok M, Allende R, Leipsic J, Abdul-Jawad Altisent O, Del Trigo M, Campelo-Parada F . Prognostic Value of Fat Mass and Skeletal Muscle Mass Determined by Computed Tomography in Patients Who Underwent Transcatheter Aortic Valve Implantation. Am J Cardiol. 2016; 117(5):828-33. DOI: 10.1016/j.amjcard.2015.12.015. View

5.
Abawi M, Rozemeijer R, Agostoni P, van Jaarsveld R, van Dongen C, Voskuil M . Effect of body mass index on clinical outcome and all-cause mortality in patients undergoing transcatheter aortic valve implantation. Neth Heart J. 2017; 25(9):498-509. PMC: 5571592. DOI: 10.1007/s12471-017-1003-2. View